R.W. Humphrey

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

M. Wayne Saville, Jill Lietzau, James M. Pluda et al. · The Lancet · 1995 · 211 citations

Hiv-associated Kaposi, Medicine, Antiviral Therapy +5

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.

Lauri Welles, M. Wayne Saville, Jill Lietzau et al. · Journal of Clinical Oncology · 1998 · 174 citations

Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology

R.W. Humphrey, Åsa Öhagen, David A. Davis et al. · Antimicrobial Agents and Chemotherapy · 1997 · 17 citations · Full text

Gag Polyprotein, Immunology, Immature Hiv-1 Virions +17

A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection

R.W. Humphrey, Kathleen M. Wyvill, Bach-Yen Nguyen et al. · Antiviral Research · 1999 · 10 citations

Hiv-1 Protease, Pharmacology, Antiviral Therapy +5